A Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy.
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Biliary cancer
- Focus Adverse reactions
- 25 May 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 26 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Feb 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health record NCT01297998).